MedPath

Real Time Amplitude Spectrum Area to Guide Defibrillation

Not Applicable
Terminated
Conditions
Ventricular Fibrillation
Out-Of-Hospital Cardiac Arrest
Interventions
Diagnostic Test: AMSA
Procedure: Defibrillation
Procedure: CPR
Registration Number
NCT03237910
Lead Sponsor
Mario Negri Institute for Pharmacological Research
Brief Summary

AMSA trial is a multicenter, randomized, controlled study in out-of-hospital cardiac arrest patients.

The purpose of the study is to test the hypothesis that a real time AMSA analysis during CPR may predict the success of defibrillation and optimize the timing of defibrillation delivery.

The primary end-point is the efficacy of the AMSA-CPR: termination of VF/VT with achievement of ROSC for an AMSA ≥ 15.5 mV-Hz

All patients meeting inclusion/exclusion criteria and receiving cardiopulmonary resuscitation are randomized into two groups: AMSA-guided CPR or standard CPR.

In the AMSA-CPR group, AMSA value suggests when the rescuer should deliver the defibrillation attempt; In the Standard-CPR group, the defibrillation is delivered based on the 2015 European Resuscitation Council (ERC) CPR guidelines.

Detailed Description

In the AMSA-CPR intervention, upon arrival of the advanced life support (ALS) rescue team at the cardiac arrest scene and application of the defibrillatory pads to the patient's chest and power on of the defibrillator with the real time AMSA analysis:

* If AMSA is ≥ 15.5 mV-Hz, an immediate defibrillation is attempted, followed by CPR

* If AMSA is \< 15.5 mV-Hz, defibrillation is not attempted and CPR is delivered

* During the 2-min cycle of CPR, AMSA is measured during pauses for ventilations (every 30 CC, approximately every 20/25 sec). If an AMSA value ≥ 15.5 mV-Hz is achieved prior to cycle completion, an immediate defibrillation is delivered (thus the defibrillation attempt is anticipated)

After completion of the first 2-min CPR cycle:

* If AMSA is ≤ 6.5 mV-Hz, the defibrillation is not attempted but CPR is continued

* If AMSA is \> 6.5 mV-Hz, an immediate defibrillation attempt is delivered, followed by CPR

* During the 2-min cycle of CPR, AMSA is measured during pauses for ventilations (every 30 CC, approximately every 20/25 sec). If an AMSA value ≥ 15.5 mV-Hz is achieved prior to cycle completion, an immediate defibrillation is delivered

After completion of the second 2-min CPR cycle and till the end of the resuscitative intervention:

• CPR is continued based on standard 2015 ERC guidelines (a defibrillation attempt every 2-min CPR cycles), except for the possibility to anticipate the defibrillation attempt if AMSA becomes ≥ 15.5 mV-Hz during the CPR cycle.

In the standard CPR intervention, upon arrival of the ALS team at the cardiac arrest scene, and application of the defibrillatory pads to the patient's chest and power on of the defibrillator:

• a defibrillation is immediately attempted and CPR is then started and continued for 2- min. Analysis of rhythm and subsequent defibrillation attempts are performed every 2-min CPR cycles.

In both study groups, the quality of CC and ventilation is monitored in real time thought the feedback integrated into the defibrillator.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
31
Inclusion Criteria

All adult patients (age ≥ 18) suffering of out-of-hospital non traumatic cardiac arrest of presumably cardiac etiology with a presenting shockable rhythm requiring electrical defibrillation: Ventricular Fibrillation and pulseless Ventricular Tachycardia.

Exclusion Criteria
  • age < 18 years old
  • pregnancy
  • cardiac arrest with a non-shockable rhythm (pulseless electrical activity and asystole)
  • a defibrillation delivered by an AED prior to ALS arrival
  • cardiac arrest of traumatic origin
  • non-cardiac cause of cardiac arrest
  • presumable irreversible death or known terminal illness at the beginning of ALS
  • clinical death
  • participation in another clinical or device trial within the previous 30 days
  • refused informed consent to the use of data.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AMSA-CPRDefibrillationThe professional rescuer decides to deliver the defibrillation attempt based on the AMSA value displayed in the defibrillator
AMSA-CPRAMSAThe professional rescuer decides to deliver the defibrillation attempt based on the AMSA value displayed in the defibrillator
Standard-CPRCPRThe defibrillation is delivered based on the 2015 European Resuscitation Council CPR guidelines
AMSA-CPRCPRThe professional rescuer decides to deliver the defibrillation attempt based on the AMSA value displayed in the defibrillator
Standard-CPRDefibrillationThe defibrillation is delivered based on the 2015 European Resuscitation Council CPR guidelines
Primary Outcome Measures
NameTimeMethod
Return of spontaneous circulation (ROSC)At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)

Termination of ventricular fibrillation with achievement of ROSC for an AMSA value ≥ 15.5 mV-Hz

Secondary Outcome Measures
NameTimeMethod
CPR durationAt day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)

duration of CPR in minutes prior to achieve ROSC

Cardiac troponinsat 6 and 24 hours after ICU admission

assessment of circulating levels of high sensitive cardiac troponin T in plasma as marker of cardiac injury

Long term survivalat 1 and 6 months after ROSC

number of patients alive after initial resuscitation

Defibrillation attemptsAt day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)

Number of defibrillations to achieve ROSC

Short term survivalat hospital admission and 24 hours after ROSC

number of patients alive after initial resuscitation

Trial Locations

Locations (2)

UOC Rianimazione-Emergenza Territoriale 118, Dipartimento di Emergenza, Ospedale Maggiore - AUSL di Bologna

🇮🇹

Bologna, Italy

SOREU Metropolitana - AREU ASST, Grande Ospedale Metropolitano Niguarda

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath